Gene expression profiles of bronchoalveolar cells in pulmonary TB

Tuberculosis

Volumn 88, Issue 1, 2008, Pages 39-51

  Raju, Bindu ^a   Hoshino, Yoshihiko ^a   Belitskaya Lévy, Ilana ^a   Dawson, Rod ^b   Ress, Stanley ^b   Gold, Jeffrey A ^a   Condos, Rany ^a   Pine, Richard ^c   Brown, Stuart ^a   Nolan, Anna ^a   Rom, William N ^a   Weiden, Michael D ^a  

^a BELLEVUE HOSPITAL CENTER   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Bronchoalveolar lavage; Functional genomics; Human; Immunity; Tuberculosis

Indexed keywords

CHEMOKINE; COMPLEMENTARY DNA; CYTOKINE; CYTOKINE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 4; ISONIAZID; RNA; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BACTERIUM CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNCTIONAL GENOMICS; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; LUNG INFECTION; LUNG LAVAGE; LUNG TUBERCULOSIS; MALE; MONOTHERAPY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPUTUM CULTURE; TUBERCULOSIS;

ADULT; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; FEMALE; GENE EXPRESSION; HUMANS; MALE; MICROARRAY ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 37249034633     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2007.07.003     Document Type: Article

References (48)

1. The New York City Department of Health and Mental Hygiene. Tuberculosis cases down 73% citywide since the peak of the NYC epidemic. 2005; Press release # 024-05 ed. 〈http://www.ci.nyc.ny.us/html/doh/html/pr/pr024-05.shtml〉.
2. Schluger N.W., and Rom W.N. The host immune response to tuberculosis. Am J Respir Crit Care Med 157 3 Pt 1 (1998) 679-691
3. Rengarajan J., Szabo S.J., and Glimcher L.H. Transcriptional regulation of Th1/Th2 polarization. Immunol Today 21 10 (2000) 479-483
4. Flynn J.L., Chan J., Triebold K.J., Dalton D.K., Stewart T.A., and Bloom B.R. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178 6 (1993) 2249-2254
5. Kamijo R., Le J., Shapiro D., Havell E.A., Huang S., Aguet M., et al. Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide. J Exp Med 178 4 (1993) 1435-1440
6. Kamijo R., Harada H., Matsuyama T., Boslan M., Gerecitano J., Shapiro D., et al. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263 5153 (1994) 1612-1615
7. MacMicking J.D., North R.J., LaCourse R., Mudgett J.S., Shah S.K., and Nathan C.F. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA 94 10 (1997) 5243-5248
8. Condos R., Rom W.N., Liu Y.M., and Schluger N.W. Local immune responses correlate with presentation and outcome in tuberculosis. Am J Respir Crit Care Med 157 3 Pt 1 (1998) 729-735
9. Law K.F., Jagirdar J., Weiden M.D., Bodkin M., and Rom W.N. Tuberculosis in HIV-positive patients: cellular response and immune activation in the lung. Am J Respir Crit Care Med 153 4 Pt 1 (1996) 1377-1384
10. Fenhalls G., Stevens L., Bezuidenhout J., Amphlett G.E., Duncan K., Bardin P., et al. Distribution of IFN-γ, IL-4, and TNF-α protein and CD8 T cells producing IL-12p40 mRNA in human lung tuberculous granulomas. Immunology 105 (2002) 325-335
11. Seah G.T., Scott G.M., and Rook G.A.W. Type 2 Cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J Infect Dis 181 (2000) 385-389
12. van Crevel R., Karyadi E., Preyers F., Leenders M., Kullberg B.J., Nelwan R.H.H., et al. Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities. J Infect Dis 181 (2000) 1194-1197
13. Mazzarella G., Bianco A., Perna F., D'Auria D., Grella E., Moascariello E., et al. T lymphocyte phenotypic profile in lung segments affected by cavitary and non-cavitary tuberculosis. Clin Exp Immunol 132 (2003) 283-288
14. Bai X., Wilson S.E., Chmura K., Feldman N.E., and Chan E.D. Morphometric analysis of Th1 and Th2 cytokine expression in human pulmonary tuberculosis. Tuberculosis 84 (2004) 375-385
15. Zhang M., Lin Y., Iyer D.V., Gong J., Abrams J.S., and Barnes P.F. T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun 63 8 (1995) 3231-3234
16. Rook G.A.W., Hernandez-Pando R., Dheda K., and Seah G.T. IL-4 in tuberculosis: implications for vaccine design. Trends Immunol 9 (2004) 483-488
17. Raju B., Hoshino Y., Kuwabara K., Belitskaya I., Prabhakar S., Canova A., et al. Aerosolized gamma interferon (IFN-gamma) induces expression of the genes encoding the IFN-gamma-inducible 10-kilodalton protein but not inducible nitric oxide synthase in the lung during tuberculosis. Infect Immun 72 3 (2004) 1275-1283
18. Gee K.R., Sun W.C., Bhalgat M.K., Upson R.H., Klaubert D.H., Latham K.A., et al. Fluorogenic substrates based on fluorinated umbelliferones for continuous assays of phosphatases and beta-galactosidases. Anal Biochem 273 1 (1999) 41-48
19. Rodriguez C.R., Fei D.T., Keyt B., and Baly D.L. A sensitive fluorometric enzyme-linked immunosorbent assay that measures vascular endothelial growth factor165 in human plasma. J Immunol Methods 219 1-2 (1998) 45-55
20. Bolstad B.M., Irizarry R.A., Astrand M., and Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19 2 (2003) 185-193
21. Irizarry R.A., Hobbs B., Collin F., Beazer-Barclay Y.D., Antonellis K.J., Scherf U., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4 2 (2003) 249-264
22. Eisen M.B., Spellma P.T., Brown P.O., and Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95 25 (1998) 14863-14868
23. Benyamini Y., and Hochberg Y. Controlling the false discovery rate: a powerful and practical approach to multiple testing. J R Statist Soc B 57 (1995) 289-300
24. Storey J. A direct approach to false discovery rates. J Roy Stat Soc Ser B 64 (2002) 479-498
25. Law K., Weiden M., Harkin T., Tchou-Wong K., Chi C., and Rom W.N. Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. Am J Respir Crit Care Med 153 2 (1996) 799-804
26. Ehrt S., Schnappinger D., Bekiranov S., Drenkow J., Shi S., Gingeras T.R., et al. Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J Exp Med 194 8 (2001) 1123-1140
27. Keller C., Lauber J., Blumenthal A., Buer J., and Ehlers S. Resistance and susceptibility to tuberculosis analysed at the transcriptome level: lessons from mouse macrophages. Tuberculosis (Edinburgh) 84 3-4 (2004) 144-158
28. Ragno S., Romano M., Howell S., Pappin D.J., Jenner P.J., and Colston M.J. Changes in gene expression in macrophages infected with Mycobacterium tuberculosis: a combined transcriptomic and proteomic approach. Immunology 104 1 (2001) 99-108
29. Wang J.P., Rought S.E., Corbeil J., and Guiney D.G. Gene expression profiling detects patterns of human macrophage responses following Mycobacterium tuberculosis infection. FEMS Immunol Med Microbiol 39 2 (2003) 163-172
30. Grassi M., Bocchino M., Marruchella A., Volpe E., Saltini C., Colizzie V., et al. Transcriptional profile of the immune response in the lungs of patients with active tuberculosis. Clin Immunol 121 1 (2006) 100-107
31. Cousins D.J., Lee T.H., and Staynov D.Z. Cytokine coexpression during human Th1/Th2 cell differentiation: direct evidence for coordinated expression of Th2 cytokines. J Immunol 169 5 (2002) 2498-2506
32. Boussiotis V.A., Tsai E.Y., Yunis E.J., Thim S., Delgado J.C., Dascher C.C., et al. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 105 9 (2000) 1317-1325
33. Delgado J.C., Tsai E.Y., Thim S., Baena A., Boussiotis V.A., Reynes J.M., et al. Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia. Proc Natl Acad Sci USA 99 11 (2002) 7576-7581
34. Tanaka N., Hoshino Y., Gold J., Hoshino S., Martiniuk F., Kurata T., et al. Interleukin-10 induces inhibitory C/EBPbeta through STAT-3 and represses HIV-1 transcription in macrophages. Am J Respir Cell Mol Biol 33 4 (2005) 406-411
35. Toossi Z., and Ellner J.J. The role of TGF beta in the pathogenesis of human tuberculosis. Clin Immunol Immunopathol 87 2 (1998) 107-114
36. Salgame P., Abrams J.S., Clayberger C., Goldstein H., Convit J., Modlin R.L., et al. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254 5029 (1991) 279-282
37. Yamamura M., Uyemura K., Deans R.J., Weinberg K., Rea T.H., and Bloom B.R. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254 5029 (1991) 277-279
38. Bleharski J.R., Li H., Meinken C., Graeber T.G., Ochoa M.T., Yamamura M., et al. Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science 301 5639 (2003) 1527-1530
39. Schwander S.K., Torres M., Sada E., Carranza C., Ramos E., Tary-Lehmann M., et al. Enhanced responses to Mycobacterium tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis. J Infect Dis 178 5 (1998) 1434-1445
40. Dieli F., Singh M., Spallek R., Romano A., Titone L., Sireci G., et al. Change of Th0 to Th1 cell-cytokine profile following tuberculosis chemotherapy. Scand J Immunol 52 1 (2000) 96-102
41. Marchant A., Amedei A., Azzurri A., Vekemans J., Benagiano M., Tamburini C., et al. Polarization of PPD-specific T-cell response of patients with tuberculosis from Th0 to Th1 profile after successful antimycobacterial therapy or in vitro conditioning with interferon-alpha or interleukin-12. Am J Respir Cell Mol Biol 24 2 (2001) 187-194
42. Dheda K., Chang J.-S., Breen R.A.M., Kim L.U., Haddock J.A., Huggett J.F., et al. In vivo and in vitro studies of a novel cytokine, interleukin 4d2, in pulmonary tuberculosis. Am J Respir Cell Mol Biol 172 (2005) 501-508
43. Verreck F.A.W., de Boer T., Langenberg D.M.L., Hoeve M.A., Kramer M., Vaisberg E., et al. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci USA 101 13 (2004) 4560-4565
44. Sousa A.O., Salem J.I., Lee F.K., et al. An epidemic of tuberculosis with a high rate of tuberculin anergy among a population previously unexposed to tuberculosis, the Yanomami Indians of the Brazilian Amazon. Proc Natl Acad Sci USA 94 (1997) 13227-13232
45. Lienhardt C., Azzurri A., Amedei A., Fielding K., Sillah J., Sow O.Y., et al. Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. Eur J Immunol 32 6 (2002) 1605-1613
46. Silver R.F., Walrath J., Jacobson B.A., Horton H., Bowman M.R., Nocka K., et al. Differential induction of human alveolar macrophage gene expression by virulent and avirulent strains of Mycobacterium tuberculosis. Am J Res Crit Care Med 173 (2006) A218
47. Spira A., Carroll J.D., Liu G., Aziz Z., Shah V., Kornfeld H., et al. Apoptosis genes in human alveolar macrophages infected with virulent or attenuated Mycobacterium tuberculosis: a pivotal role for tumor necrosis factor. Am J Respir Cell Mol Biol 29 5 (2003) 545-551
48. Zhu G., Xiao H., Mohan V.P., Tanaka K., Tyagi S., Tsen F., et al. Gene expression in the tuberculous granuloma: analysis by laser capture microdissection and real-time PCR. Cell Microbiol 5 7 (2003) 445-453